Clinical trials
Completed Asperger Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
58 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 7 |
| 2010 | 6 |
| 2011 | 5 |
| 2012 | 4 |
| 2013 | 6 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 58 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of South Florida | 6 |
| Massachusetts General Hospital | 4 |
| Yale University | 4 |
| Indiana University | 3 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2 |
| Forest Laboratories | 2 |
| Icahn School of Medicine at Mount Sinai | 2 |
| Montefiore Medical Center | 2 |
| National Institute of Mental Health (NIMH) | 2 |
| University of North Carolina, Chapel Hill | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asperger Syndrome | 58 |
| Autistic Disorder | 46 |
| Autism Spectrum Disorder | 33 |
| Child Development Disorders, Pervasive | 26 |
| Attention Deficit Disorder with Hyperactivity | 7 |
| Obsessive-Compulsive Disorder | 7 |
| Anxiety Disorders | 6 |
| Anxiety, Separation | 5 |
| Generalized Anxiety Disorder | 5 |
| Phobia, Social | 5 |
Trials
Showing 1 to 25 of 58. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.